KOKA Lifesciences (Nantong) in Chongchuan district, Nantong, Jiangsu province was included on the Hurun Global Cheetah Index 2023, which was released on Dec 19.

Established in September 2018, KOKA Lifesciences is a cutting-edge biopharmaceutical technology company focusing on the research, production, and sale of medical devices specifically designed for structural heart diseases.

KOKA Lifesciences is a pioneer in China's interventional heart valve device industry. The company's expertise lies in developing comprehensive solutions for valve diseases tailored to various populations, needs, and situations. Its technical prowess is the result of research and development professionals who have returned from the United States and Germany, boasting years of experience in the cardiovascular medical sector.

The Hurun Global Cheetah Index 2023 ranks the world's most promising high-growth enterprises established after the year 2000, which are predicted to achieve unicorn status, meaning a valuation of over $1 billion within five years.

As of the valuation deadline on Dec 31, 2022, companies on the index are generally valued between $300 million to $500 million.

KOKA Lifesciences. [Photo/WeChat account: chongchuanonline]